[#item_full_content] The FDA moved approved marijuana products to schedule III to expand therapy access and state medical programs while maintaining federal controls. 
Read More
[#item_full_content] The FDA moved approved marijuana products to schedule III to expand therapy access and state medical programs while maintaining federal controls. Read More